MDHearing Neo XS vs Otofonix Groove

The MDHearing Neo XS is a budget-priced OTC hearing aid in the invisible-in-ear style, available for $397. In HearAdvisor lab testing, it earned a C grade with a SoundScore of 2.9/5, ranking #63 of 65 OTC hearing aids tested. Performance results reveal a mixed profile. The Neo XS shows strength in own-voice comfort, scoring 3.2/5—0.69 points above the category average—meaning wearers may experience less of the "boomy" quality that can accompany hearing aid use. Feedback handling is excellent at 5.0/5, sitting 0.46 points above average, so users should experience stable performance without whistling during typical wear. However, speech clarity is a significant limitation. Speech in quiet scores just 1.0/5, falling 1.77 points below the OTC category average. Speech in noise also scores 1.0/5, 0.48 points below average. Music streaming scored 0.0/5, which is 1.92 points below the category average—this device is not suited for audio entertainment. At this price point, several alternatives offer notably stronger performance. The Elehear Beyond (4.36/5), Apple AirPods Pro 2 (4.06/5), and Zepp Clarity Omni (3.88/5) all deliver better overall sound quality in the same price range. The Neo XS may appeal to those prioritizing own-voice comfort and feedback stability over speech intelligibility, but most users seeking meaningful hearing benefit should consider higher-scoring options.

The Otofonix Groove is a behind-the-ear prescription hearing aid priced at $795, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This rechargeable BTE device ranks 36th out of 36 tested prescription hearing aids, placing it in the bottom tier of its category. In our testing, the Groove demonstrated one clear strength: excellent feedback handling at 5.0/5, scoring 0.29 points above the category average. The device remained stable during our standardized challenge motions with no audible feedback issues. However, speech performance was significantly limited, with both speech in quiet and speech in noise scoring 1.0/5—falling 2.32 and 0.96 points below their respective category averages. Music streaming quality scored 0.0/5, which is 2.64 points below the prescription category average. Own-voice comfort was also low at 0.4/5 in the tuned configuration, 2.35 points below average, suggesting notable occlusion-related concerns. The normalized Initial Score of 2.7/5 and Tuned Score of 2.6/5 indicate that professional fitting adjustments did not improve overall performance. Given its positioning at the bottom of the prescription hearing aid category and the availability of lower-priced alternatives that scored higher in our testing, the Otofonix Groove may be difficult to recommend for most users seeking balanced sound quality across listening situations.